Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

COVID-19 and the Angiotensin-Converting Enzyme 1 D/I Genotype: Protection of People at High-Risk by Predicting the Severity of the Disease

Naoki Yamamoto

Throughout history, humans have been threatened by various infectious diseases. As of August 22, 2020, a new coronavirus infection, COVID-19, has been raging around the world, infecting approximately 23 million people and killing approximately 800,000. Although COVID-19 is a serious infectious disease, it is at most comparable to the 1968 Hong Kong flu given the far more deaths caused by previous devastations, such as the plague, smallpox, Spanish flu, AIDS, tuberculosis and malaria. However, we are still in the midst of the epidemic, and it is difficult to project the extent of damage COVID-19 will ultimately inflict.